In vivo studies demonstrated that inhibition or induction of ABCB1 in multidrug resistant tumor cells influences the intratumoral paclitaxel exposure (Huisman et al., 2005; Tiwari et al., 2013). This evidence concerns the gene ABCB1 and neoplasm.